EXL Tops ISG’s 2026 Healthcare AI Report as Leader in Strategy and Delivery
Event summary
- EXL recognized as a Leader in both Healthcare AI Strategy and AI Development quadrants of ISG’s 2026 report.
- ISG cited EXL’s ability to scale AI from pilots to enterprise-wide healthcare workflows.
- EXL’s agentic architecture integrates AI into claims, care coordination, and payer functions.
- Report highlights measurable ROI, reduced patient risk, cost monitoring, and bias elimination.
The big picture
EXL’s dual recognition underscores a broader industry shift toward operationalizing AI in healthcare, moving beyond experimental pilots to scalable, ROI-driven deployments. The firm’s embedded AI approach aligns with growing demand for integrated, data-driven solutions that reduce costs and improve patient outcomes. This positions EXL as a key player in a market where AI adoption is accelerating but faces challenges in governance and execution.
What we're watching
- Scalability Challenges
- How EXL will sustain enterprise-wide AI integration across diverse healthcare workflows.
- Competitive Differentiation
- Whether EXL’s agentic architecture can maintain a lead over competitors in measurable outcomes.
- Regulatory Compliance
- The pace at which governance frameworks adapt to EXL’s AI-driven healthcare solutions.
Related topics